CENTAURO-4 Study |
Nimotuzumab-pancreatic cancer-adults-Phase IV. |
HEBERBIOVAC HB vaccine to reference material. |
Safety and immunogenicity of VCN7-T in infants of 2 and 3 months. Phase I/II. |
Hepatotoxicity by drugs |
Study of the mechanism of action of Nimotuzumab in patients with head and neck tumors |
Combined sublingual immunotherapy VALERGEN-DP and VALERGEN-BT-Asthma-Adults-Phase II |
Paclitaxel/Radiotherapy/Cisplatino for cervical cancer |
Phase I with CIGB-814 in rheumatoid arthritis patients |
CENTAURO-6 Study |
Ozone-Therapy-Immunoglobulin A deficiency-adults and childrens-Phase II |
Cuban uterine manipulator, new device for the hysterectomy totally laparoscopic. |
Phase I/II trial with the mutein no alfa of IL-2 |
NeuroEPO in patients with Parkinson disease stage II-III |
NeuroEPO in patients with Mild-Moderate Alzheimer's disease |
Pharmacovigilance-VALERGEN-Asthma |
ESAR-814 Study |
HEBERFERON in renal cell carcinoma |
CV638 ability to protect against homologous Vibrio cholerae 3008 virulent strain |
Policosanol in patients with metabolic syndrome and ischaemic cardiopaty |